[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware
(State or other jurisdiction of
incorporation or organization) |
51-0263969
(I.R.S. Employer Identification No.)
|
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida (Address of principal executive offices) |
34240
(Zip Code)
|
(941) 556-2601
(Registrant's telephone number, including area code)
|
þ Large accelerated filer
|
¨ Accelerated filer
|
¨ Non-accelerated filer
(do not check if smaller reporting company)
|
¨ Smaller reporting company
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
Item 1.
|
Financial Statements (unaudited):
|
|
|
Condensed Consolidated Statements of Earnings
|
3
|
|
Condensed Consolidated Statements of Comprehensive Income
|
4
|
|
Condensed Consolidated Balance Sheets
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Condensed Consolidated Statement of Changes in Stockholders' Equity
|
7
|
|
Notes to Condensed Consolidated Financial Statements
|
8
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
13
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
19
|
Item 4.
|
Controls and Procedures
|
19
|
PART II.
|
OTHER INFORMATION
|
|
Item 1.
|
Legal Proceedings
|
20
|
Item 1A.
|
Risk Factors
|
20
|
Item 6.
|
Exhibits
|
20
|
|
Signatures
|
21
|
PART I. | FINANCIAL INFORMATION |
|
|
Three months ended
March 31, |
|
||||
|
|
2014
|
|
2013
|
|
||
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
834,052
|
|
$
|
737,135
|
|
Cost of sales
|
|
|
345,116
|
|
|
315,559
|
|
Gross profit
|
|
|
488,936
|
|
|
421,576
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
265,536
|
|
|
236,399
|
|
Income from operations
|
|
|
223,400
|
|
|
185,177
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
19,827
|
|
|
20,858
|
|
Other income/(expense), net
|
|
|
1,420
|
|
|
(2,492
|
)
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
204,993
|
|
|
161,827
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
|
57,767
|
|
|
36,913
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
147,226
|
|
$
|
124,914
|
|
|
|
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.48
|
|
$
|
1.26
|
|
Diluted
|
|
|
1.46
|
|
|
1.25
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
|
|
99,557
|
|
|
98,876
|
|
Diluted
|
|
|
100,572
|
|
|
99,986
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.200
|
|
$
|
0.165
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
March 31, |
|
|||||
|
|
2014
|
|
|
2013
|
|
||
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
147,226
|
|
|
$
|
124,914
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/(loss), net of tax:
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
(12,811
|
)
|
|
|
(38,489
|
)
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income/(loss), net of tax
|
|
|
(12,811
|
)
|
|
|
(38,489
|
)
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
134,415
|
|
|
$
|
86,425
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
|
||
ASSETS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
502,885
|
|
$
|
459,720
|
|
Accounts receivable, net
|
|
|
514,081
|
|
|
519,075
|
|
Inventories, net
|
|
|
209,383
|
|
|
204,923
|
|
Deferred taxes
|
|
|
70,069
|
|
|
64,464
|
|
Unbilled receivables
|
|
|
95,274
|
|
|
86,945
|
|
Other current assets
|
|
|
40,478
|
|
|
38,210
|
|
Total current assets
|
|
|
1,432,170
|
|
|
1,373,337
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
116,590
|
|
|
117,310
|
|
Goodwill
|
|
|
4,540,022
|
|
|
4,549,998
|
|
Other intangible assets, net
|
|
|
1,997,924
|
|
|
2,039,136
|
|
Deferred taxes
|
|
|
27,196
|
|
|
28,773
|
|
Other assets
|
|
|
75,801
|
|
|
76,427
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
8,189,703
|
|
$
|
8,184,981
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
144,168
|
|
$
|
150,313
|
|
Accrued compensation
|
|
|
92,820
|
|
|
107,953
|
|
Deferred revenue
|
|
|
207,957
|
|
|
209,332
|
|
Other accrued liabilities
|
|
|
162,559
|
|
|
153,712
|
|
Income taxes payable
|
|
|
43,035
|
|
|
4,275
|
|
Deferred taxes
|
|
|
6,511
|
|
|
6,490
|
|
Current portion of long-term debt, net
|
|
|
10,923
|
|
|
11,016
|
|
Total current liabilities
|
|
|
667,973
|
|
|
643,091
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
2,304,143
|
|
|
2,453,836
|
|
Deferred taxes
|
|
|
771,243
|
|
|
783,805
|
|
Other liabilities
|
|
|
89,099
|
|
|
91,199
|
|
Total liabilities
|
|
|
3,832,458
|
|
|
3,971,931
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1,017
|
|
|
1,013
|
|
Additional paid-in capital
|
|
|
1,258,910
|
|
|
1,229,233
|
|
Retained earnings
|
|
|
3,086,465
|
|
|
2,959,196
|
|
Accumulated other comprehensive earnings
|
|
|
30,272
|
|
|
43,083
|
|
Treasury stock
|
|
|
(19,419
|
)
|
|
(19,475
|
)
|
Total stockholders' equity
|
|
|
4,357,245
|
|
|
4,213,050
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
8,189,703
|
|
$
|
8,184,981
|
|
|
|
Three months ended
March 31, |
|
||||||
|
|
2014
|
|
|
2013
|
|
|||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
147,226
|
|
|
$
|
124,914
|
|
|
Adjustments to reconcile net earnings to cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization of property, plant and equipment
|
|
|
9,666
|
|
|
|
9,342
|
|
|
Amortization of intangible assets
|
|
|
39,037
|
|
|
|
34,099
|
|
|
Amortization of deferred financing costs
|
|
|
1,002
|
|
|
|
837
|
|
|
Non-cash stock compensation
|
|
|
14,571
|
|
|
|
12,977
|
|
|
Changes in operating assets and liabilities, net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
4,582
|
|
|
|
27,590
|
|
|
Unbilled receivables
|
|
|
(8,346
|
)
|
|
|
(13,136
|
)
|
|
Inventories
|
|
|
(4,712
|
)
|
|
|
(11,687
|
)
|
|
Accounts payable and accrued liabilities
|
|
|
(12,887
|
)
|
|
|
(25,510
|
)
|
|
Income taxes payable
|
|
|
24,829
|
|
|
|
16,348
|
|
|
Other, net
|
|
|
(2,340
|
)
|
|
|
(4,506
|
)
|
|
Cash provided by operating activities
|
|
|
212,628
|
|
|
|
171,268
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of cash acquired
|
|
|
(2,146
|
)
|
|
|
(2,240
|
)
|
|
Capital expenditures
|
|
|
(10,478
|
)
|
|
|
(11,205
|
)
|
|
Proceeds from sale of assets
|
|
|
341
|
|
|
|
236
|
|
|
Other, net
|
|
|
(233
|
)
|
|
|
(1
|
)
|
|
Cash used in investing activities
|
|
|
(12,516
|
)
|
|
|
(13,210
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Payments under revolving line of credit
|
|
|
(150,000
|
)
|
|
|
(100,000
|
)
|
|
Principal payments on convertible notes
|
|
|
(433
|
)
|
|
|
(52
|
)
|
|
Cash premiums paid on convertible note conversions
|
|
|
(1,174
|
)
|
|
|
(109
|
)
|
|
Cash dividends to stockholders
|
|
|
(19,863
|
)
|
|
|
-
|
|
|
Proceeds from stock based compensation, net
|
|
|
8,026
|
|
|
|
6,229
|
|
|
Stock award tax excess windfall benefit
|
|
|
7,511
|
|
|
|
4,364
|
|
|
Treasury stock sales
|
|
|
729
|
|
|
|
642
|
|
|
Other
|
|
|
573
|
|
|
|
122
|
|
|
Cash used in financing activities
|
|
|
(154,631
|
)
|
|
|
(88,804
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Effect of foreign currency exchange rate changes on cash
|
|
|
(2,316
|
)
|
|
|
(9,822
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
43,165
|
|
|
|
59,432
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
459,720
|
|
|
|
370,590
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
$
|
502,885
|
|
|
$
|
430,022
|
|
|
|
Common
stock |
|
Additional paid-in capital
|
|
Retained
earnings
|
|
Accumulated other comprehensive earnings
|
|
Treasury
stock
|
|
Total
|
|
||||||
Balances at December 31, 2013
|
|
$
|
1,013
|
|
$
|
1,229,233
|
|
$
|
2,959,196
|
|
$
|
43,083
|
|
$
|
(19,475
|
)
|
$
|
4,213,050
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
|
-
|
|
|
-
|
|
|
147,226
|
|
|
-
|
|
|
-
|
|
|
147,226
|
|
Stock option exercises
|
|
|
2
|
|
|
9,951
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
9,953
|
|
Treasury stock sold
|
|
|
-
|
|
|
673
|
|
|
-
|
|
|
-
|
|
|
56
|
|
|
729
|
|
Currency translation adjustments, net of $1,278 tax
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(12,811
|
)
|
|
-
|
|
|
(12,811
|
)
|
Stock based compensation
|
|
|
-
|
|
|
14,569
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
14,569
|
|
Restricted stock activity
|
|
|
2
|
|
|
(1,930
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(1,928
|
)
|
Stock option tax benefit, net of shortfalls
|
|
|
-
|
|
|
7,485
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
7,485
|
|
Conversion of senior subordinated convertible notes, net of $103 tax
|
|
|
-
|
|
|
(1,071
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(1,071
|
)
|
Dividends declared
|
|
|
-
|
|
|
-
|
|
|
(19,957
|
)
|
|
-
|
|
|
-
|
|
|
(19,957
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at March 31, 2014
|
|
$
|
1,017
|
|
$
|
1,258,910
|
|
$
|
3,086,465
|
|
$
|
30,272
|
|
$
|
(19,419
|
)
|
$
|
4,357,245
|
|
1.
|
Basis of Presentation
|
2.
|
Recent Accounting Pronouncements
|
3.
|
Earnings Per Share
|
|
|
Three months ended
March 31,
|
|
||
|
|
2014
|
|
2013
|
|
Basic shares outstanding
|
|
99,557
|
|
98,876
|
|
Effect of potential common stock
|
|
|
|
|
|
Common stock awards
|
|
864
|
|
892
|
|
Senior subordinated convertible notes
|
|
151
|
|
218
|
|
Diluted shares outstanding
|
|
100,572
|
|
99,986
|
|
4.
|
Stock Based Compensation
|
|
Three months ended
March 31, |
|
|
2014
|
2013
|
Stock based compensation
|
$ 14,571
|
$ 12,977
|
Tax effect recognized in net income
|
5,100
|
4,542
|
Windfall tax benefit, net
|
7,485
|
4,312
|
|
Three months ended March 31,
|
||
|
2014
|
|
2013
|
Risk-free interest rate (%)
|
1.62
|
|
0.80
|
Expected option life (years)
|
5.24
|
|
5.18
|
Expected volatility (%)
|
27.62
|
|
36.29
|
Expected dividend yield (%)
|
0.59
|
|
0.57
|
5.
|
Inventories
|
|
|
March 31,
2014 |
|
December 31,
2013 |
|
|||
Raw materials and supplies
|
|
$
|
130,481
|
|
$
|
127,525
|
|
|
Work in process
|
|
|
32,650
|
|
|
30,498
|
|
|
Finished products
|
|
|
90,056
|
|
|
90,352
|
|
|
Inventory reserves
|
|
|
(43,804
|
)
|
|
(43,452
|
)
|
|
|
|
$
|
209,383
|
|
$
|
204,923
|
|
6.
|
Goodwill and Other Intangible Assets
|
|
Industrial Technology
|
|
Energy Systems & Controls
|
|
Medical & Scientific Imaging
|
|
RF Technology
|
|
Total
|
|
|||||
Balances at December 31, 2013
|
$
|
425,501
|
|
$
|
434,697
|
|
$
|
2,435,506
|
|
$
|
1,254,294
|
|
$
|
4,549,998
|
|
Other
|
|
-
|
|
|
-
|
|
|
(2,266
|
)
|
|
-
|
|
|
(2,266
|
)
|
Currency translation adjustments
|
|
591
|
|
|
(294
|
)
|
|
(8,062
|
)
|
|
55
|
|
|
(7,710
|
)
|
Balances at March 31, 2014
|
$
|
426,092
|
|
$
|
434,403
|
|
$
|
2,425,178
|
|
$
|
1,254,349
|
|
$
|
4,540,022
|
|
|
|
Cost
|
|
Accumulated
amortization |
|
Net book
value |
|
|||
Assets subject to amortization:
|
|
|
|
|
|
|
|
|||
Customer related intangibles
|
|
$
|
1,936,336
|
|
$
|
(464,018
|
)
|
$
|
1,472,318
|
|
Unpatented technology
|
|
|
216,044
|
|
|
(120,091
|
)
|
|
95,953
|
|
Software
|
|
|
160,618
|
|
|
(58,084
|
)
|
|
102,534
|
|
Patents and other protective rights
|
|
|
31,394
|
|
|
(21,922
|
)
|
|
9,472
|
|
Trade names
|
|
|
656
|
|
|
(16
|
)
|
|
640
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
358,219
|
|
|
-
|
|
|
358,219
|
|
Balances at December 31, 2013
|
|
$
|
2,703,267
|
|
$
|
(664,131
|
)
|
$
|
2,039,136
|
|
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,933,576
|
|
$
|
(491,047
|
)
|
$
|
1,442,529
|
|
Unpatented technology
|
|
|
209,107
|
|
|
(120,104
|
)
|
|
89,003
|
|
Software
|
|
|
152,441
|
|
|
(53,116
|
)
|
|
99,325
|
|
Patents and other protective rights
|
|
|
29,699
|
|
|
(20,589
|
)
|
|
9,110
|
|
Trade names
|
|
|
663
|
|
|
(32
|
)
|
|
631
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
357,326
|
|
|
-
|
|
|
357,326
|
|
Balances at March 31, 2014
|
|
$
|
2,682,812
|
|
$
|
(684,888
|
)
|
$
|
1,997,924
|
|
7.
|
Debt
|
8.
|
Fair Value of Financial Instruments
|
$400 million senior notes due 2017
|
$ 400
|
$800 million senior notes due 2018
|
790
|
$500 million senior notes due 2019
|
580
|
$500 million senior notes due 2022
|
475
|
9.
|
Contingencies
|
Balance at December 31, 2013
|
|
$
|
14,336
|
|
Additions charged to costs and expenses
|
|
|
3,305
|
|
Deductions
|
|
|
(4,072
|
)
|
Other
|
|
|
(41
|
)
|
Balance at March 31, 2014
|
|
$
|
13,528
|
|
10.
|
Business Segments
|
|
|
Three months ended March 31,
|
|
|
|
||||
|
|
2014
|
|
2013
|
|
Change
|
|
||
Net sales:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
197,001
|
|
$
|
182,239
|
|
8.1
|
%
|
Energy Systems & Controls
|
|
|
155,171
|
|
|
145,642
|
|
6.5
|
|
Medical & Scientific Imaging
|
|
|
256,199
|
|
|
200,444
|
|
27.8
|
|
RF Technology
|
|
|
225,681
|
|
|
208,810
|
|
8.1
|
|
Total
|
|
$
|
834,052
|
|
$
|
737,135
|
|
13.1
|
%
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
98,470
|
|
$
|
93,311
|
|
5.5
|
%
|
Energy Systems & Controls
|
|
|
85,965
|
|
|
80,906
|
|
6.3
|
|
Medical & Scientific Imaging
|
|
|
184,850
|
|
|
134,869
|
|
37.1
|
|
RF Technology
|
|
|
119,651
|
|
|
112,490
|
|
6.4
|
|
Total
|
|
$
|
488,936
|
|
$
|
421,576
|
|
16.0
|
%
|
Operating profit*:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
56,056
|
|
$
|
52,945
|
|
5.9
|
%
|
Energy Systems & Controls
|
|
|
37,025
|
|
|
35,722
|
|
3.6
|
|
Medical & Scientific Imaging
|
|
|
89,771
|
|
|
59,928
|
|
49.8
|
|
RF Technology
|
|
|
62,560
|
|
|
56,630
|
|
10.5
|
|
Total
|
|
$
|
245,412
|
|
$
|
205,225
|
|
19.6
|
%
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
49,022
|
|
$
|
45,626
|
|
7.4
|
%
|
Energy Systems & Controls
|
|
|
18,503
|
|
|
19,032
|
|
(2.8
|
)
|
Medical & Scientific Imaging
|
|
|
39,948
|
|
|
40,198
|
|
(0.6
|
)
|
RF Technology
|
|
|
29,714
|
|
|
29,158
|
|
1.9
|
|
Total
|
|
$
|
137,187
|
|
$
|
134,014
|
|
2.4
|
%
|
·
|
general economic conditions;
|
·
|
difficulty making acquisitions and successfully integrating acquired businesses;
|
·
|
any unforeseen liabilities associated with future acquisitions;
|
·
|
limitations on our business imposed by our indebtedness;
|
·
|
unfavorable changes in foreign exchange rates;
|
·
|
difficulties associated with exports;
|
·
|
risks and costs associated with our international sales and operations;
|
·
|
increased directors' and officers' liability and other insurance costs;
|
·
|
risk of rising interest rates;
|
·
|
product liability and insurance risks;
|
·
|
increased warranty exposure;
|
·
|
future competition;
|
·
|
the cyclical nature of some of our markets;
|
·
|
reduction of business with large customers;
|
·
|
risks associated with government contracts;
|
·
|
changes in the supply of, or price for, raw materials, parts and components;
|
·
|
environmental compliance costs and liabilities;
|
·
|
risks and costs associated with asbestos-related litigation;
|
·
|
potential write-offs of our substantial goodwill and other intangible assets;
|
·
|
our ability to successfully develop new products;
|
·
|
failure to protect our intellectual property;
|
·
|
the effect of, or change in, government regulations (including tax);
|
·
|
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
|
·
|
the factors discussed in other reports filed with the SEC.
|
|
|
Three months ended March 31,
|
|
||||
|
|
2014
|
|
2013
|
|
||
Net sales:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
197,001
|
|
$
|
182,239
|
|
Energy Systems & Controls
|
|
|
155,171
|
|
|
145,642
|
|
Medical & Scientific Imaging
|
|
|
256,199
|
|
|
200,444
|
|
RF Technology
|
|
|
225,681
|
|
|
208,810
|
|
Total
|
|
$
|
834,052
|
|
$
|
737,135
|
|
Gross profit:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
50.0
|
%
|
|
51.2
|
%
|
Energy Systems & Controls
|
|
|
55.4
|
|
|
55.6
|
%
|
Medical & Scientific Imaging
|
|
|
72.2
|
|
|
67.3
|
%
|
RF Technology
|
|
|
53.0
|
|
|
53.9
|
%
|
Total
|
|
|
58.6
|
|
|
57.2
|
%
|
Selling, general & administrative expenses:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
21.5
|
%
|
|
22.2
|
%
|
Energy Systems & Controls
|
|
|
31.5
|
|
|
31.0
|
|
Medical & Scientific Imaging
|
|
|
37.1
|
|
|
37.4
|
|
RF Technology
|
|
|
25.3
|
|
|
26.8
|
|
Total
|
|
|
29.2
|
|
|
29.4
|
|
Segment operating profit:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
28.5
|
%
|
|
29.1
|
%
|
Energy Systems & Controls
|
|
|
23.9
|
|
|
24.5
|
|
Medical & Scientific Imaging
|
|
|
35.0
|
|
|
29.9
|
|
RF Technology
|
|
|
27.7
|
|
|
27.1
|
|
Total
|
|
|
29.4
|
|
|
27.8
|
|
Corporate administrative expenses
|
|
|
(2.6
|
)
|
|
(2.7
|
)
|
|
|
|
26.8
|
|
|
25.1
|
|
Interest expense
|
|
|
(2.4
|
)
|
|
(2.8
|
)
|
Other income/(expense)
|
|
|
0.2
|
|
|
(0.3
|
)
|
Earnings before income taxes
|
|
|
24.6
|
|
|
22.0
|
|
Income taxes
|
|
|
(6.9
|
)
|
|
(5.0
|
)
|
Net earnings
|
|
|
17.7
|
%
|
|
16.9
|
%
|
|
|
Net orders booked for the
three months ended March 31, |
|
Order backlog as of March 31,
|
|
||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
||||
|
|
(in thousands)
|
|
||||||||||
Industrial Technology
|
|
$
|
204,881
|
|
$
|
179,807
|
|
$
|
128,113
|
|
$
|
126,993
|
|
Energy Systems & Controls
|
|
|
150,915
|
|
|
157,537
|
|
|
127,445
|
|
|
120,921
|
|
Medical & Scientific Imaging
|
|
|
256,340
|
|
|
216,121
|
|
|
290,402
|
|
|
247,959
|
|
RF Technology
|
|
|
234,345
|
|
|
240,118
|
|
|
517,736
|
|
|
501,065
|
|
Total
|
|
$
|
846,481
|
|
$
|
793,583
|
|
$
|
1,063,696
|
|
$
|
996,938
|
|
|
2014
|
2013
|
||||||
Cash provided by/(used in):
|
||||||||
Operating activities
|
$
|
212.6
|
$
|
171.3
|
||||
Investing activities
|
(12.5
|
)
|
(13.2
|
)
|
||||
Financing activities
|
(154.6
|
)
|
(88.8
|
)
|
$400 million senior notes due 2017
|
$
|
400,000
|
|
$800 million senior notes due 2018
|
|
800,000
|
|
$500 million senior notes due 2019
|
|
500,000
|
|
$500 million senior notes due 2022
|
|
500,000
|
|
Senior Subordinated Convertible Notes
|
|
7,910
|
|
Revolving Facility
|
|
100,000
|
|
Other
|
|
7,156
|
|
Total debt
|
|
2,315,066
|
|
Less current portion
|
|
10,923
|
|
Long-term debt
|
$
|
2,304,143
|
|
|
|
March 31,
2014 |
|
|
|
December 31,
2013
|
|
||
Total Debt
|
|
$
|
2,315,066
|
|
|
|
$
|
2,464,852
|
|
Cash
|
|
|
(502,885
|
)
|
|
|
|
(459,720
|
)
|
Net Debt
|
|
|
1,812,181
|
|
|
|
|
2,005,132
|
|
Stockholders' Equity
|
|
|
4,357,245
|
|
|
|
|
4,213,050
|
|
Total Net Capital
|
|
$
|
6,169,426
|
|
|
|
$
|
6,218,182
|
|
|
|
|
|
|
|
|
|
|
|
Net Debt / Total Net Capital
|
|
|
29.4
|
%
|
|
|
|
32.3
|
%
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
|
|
|
/s/ Brian D. Jellison
|
|
Chairman of the Board, President,
|
May 2, 2014
|
Brian D. Jellison
|
|
and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
/s/ John Humphrey
|
|
Chief Financial Officer and
|
May 2, 2014
|
John Humphrey
|
|
Executive Vice President
|
|
|
|
(Principal Financial Officer)
|
|
/s/ Paul J. Soni
|
|
Vice President and Controller
|
May 2, 2014
|
Paul J. Soni
|
|
(Principal Accounting Officer)
|
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
|
|
|
|
|
|